HUMA
NASDAQStockHumacyte, Inc.
$1.15-0.04 (-3.36%)
52-Week Range
$0.89
$3.32
Key Stats
Market Cap
164.2M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.93
Volume
2.7M
Avg Volume
4.2M
Performance
1M
+12.87%
3M
-3.39%
6M
-25.49%
YTD
+16.92%
1Y
-58.84%
3Y
-61.74%
5Y
-90.66%
Price Chart
ETF Exposure
HUMA is held by 33 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SPXZ | Morgan Creek - Exos SPAC Originated ETF | 1.50% |
| IWC | iShares Micro-Cap ETF | 0.04% |
| IBB | iShares Biotechnology ETF | 0.02% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.02% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.01% |
| IWN | iShares Russell 2000 Value ETF | 0.01% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.01% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.00% |
| UWM | ProShares - Ultra Russell2000 | 0.00% |
| VHT | Vanguard Health Care ETF | 0.00% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
About HUMA ETF Exposure
Humacyte, Inc. (HUMA) is held by 33 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 164.2M, HUMA is a widely held institutional stock. The stock currently trades at $1.15. Investors can gain exposure to HUMA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold HUMA, sorted by portfolio weight.